Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-24-001313

CHIEF EXECUTIVE OFFICER acquired 240,530 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Thye Dirk CHIEF EXECUTIVE OFFICER 2024-01-16 Option exercise +90,531 $0.55 $49,792 539,442 D
Thye Dirk CHIEF EXECUTIVE OFFICER 2024-01-16 Option exercise +149,999 $0.94 $140,999 689,441 D
Derivatives
Thye Dirk CHIEF EXECUTIVE OFFICER 2024-01-16 Option exercise · Employee Stock Option (right to buy) −90,531 115,860 D
Thye Dirk CHIEF EXECUTIVE OFFICER 2024-01-16 Option exercise · Employee Stock Option (right to buy) −149,999 450,001 D
Loading xslF345X05/form4-01172024_090120.xml…